Dysmenorrhea – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033


 

Dysmenorrhea is a Greek term for "painful monthly bleeding." Dysmenorrhea can be classified as primary and secondary dysmenorrhea. Primary dysmenorrhea is a lower abdominal pain during the menstrual cycle, not associated with other diseases or pathology. In contrast, secondary dysmenorrhea is usually associated with other pathology inside or outside the uterus. Dysmenorrhea is a common complaint among women during their reproductive age. Dysmenorrhea is associated with significant emotional, psychological, and functional health impacts. During menstruation, chemicals called "prostaglandins" form in the lining of the uterus. They cause muscle contractions in the uterus, which can trigger pain and decrease blood flow and oxygen to the uterus. Similar to labor pains, these contractions can cause significant pain and discomfort. Prostaglandins may also contribute to other menstrual symptoms, such as nausea and diarrhea. Associated risk factors are:

  • Age
  • Smoking
  • Attempts to lose weight
  • Higher body mass index
  • Depression/anxiety
  • Earlier age at menarche
  • Nulliparity
  • Longer and heavier menstrual flow
  • Family history of dysmenorrhea
  • Disruption of social networks

The pain of dysmenorrhea is crampy and usually located in the lower abdomen; some people also have severe pain in the back or thighs. The pain usually begins just before or as menstrual bleeding begins and gradually improves over one to three days. The pain usually occurs intermittently and can range from mild to disabling. Other symptoms accompanying cramping include nausea, diarrhea, dizziness, fatigue, headache, or a flu-like feeling. The pathophysiology of primary dysmenorrhea is not well understood. Nevertheless, the identified cause is due to the hypersecretion of the prostaglandins from the uterine inner lining. Prostaglandin F2alpha (PGF-2a) and Prostaglandin PGF 2 increase the uterine tone and also causes high-amplitude contractions of the uterus. Also, vasopressin has been linked to primary dysmenorrhea. Vasopressin increases uterine contractility and can cause ischemic pain due to its vasoconstriction effects. Progesterone levels drop before menstruation, increasing PG production and triggering dysmenorrhea. Endometriosis and adenomyosis are the most common causes of secondary dysmenorrhea in premenopausal women. Secondary dysmenorrhea complication varies depending on the etiology. Complications may include infertility, pelvic organ prolapse, heavy bleeding, and anemia.

Thelansis’s “Dysmenorrhea Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Dysmenorrhea treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Dysmenorrhea across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Dysmenorrhea Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Dysmenorrhea – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Comments

Popular posts from this blog

Retinitis Pigmentosa (RP) – Market Access and Reimbursement Insights Report – 2025

Motor Neurone Disease (MND) – Market Access and Reimbursement Insights Report – 2025

Uncomplicated Gonorrhea – Market Outlook, Epidemiology, Competitive Landscape and Market Forecast Report – 2024 To 2034